Author

Anne de Snaijer

Erasmus MC

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Agatheeswaran SubramaniamiD· 1 shared Akin Bucakci· 1 shared David Linfeldt· 1 shared Els ManselliD· 1 shared Eric M. BindelsiD· 1 shared Fredrik EkiD· 1 shared Gregory van BeekiD· 1 shared Jenny HanssoniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Agatheeswaran SubramaniamORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer-associated KBTBD4 mutations induce differentiation defects and confer a unique therapeutic vulnerability

Rohit Sivaprasad, Kristijonas Žemaitis, David Linfeldt, Sudip Ghosh, Anne de Snaijer, Mattias Magnusson, Fredrik Ek, Jenny Hansson, Agatheeswaran Subramaniam

This study models KBTBD4 mutations in hematopoietic stem cells, identifies HDAC inhibitors as therapeutic agents, and reveals their mechanism of action.

Cancer Gene Therapy · Aug 10, 2026Peer-reviewedCancer Biology

Targeting mitochondria mitigates chemotherapy-induced bone marrow dysfunction

Tim V. D. van Tienhoven, Johanna Lepland, Anne de Snaijer, Akin Bucakci, Wout Maaskant, Gregory van Beek, Eric M. Bindels, Marc H.G.P. Raaijmakers, Tariq Enver, Valgarður Sigurðsson, Els Mansell

This paper shows that chemotherapy causes long-term bone marrow dysfunction by impairing hematopoietic stem cells, which can be reversed by mitochondrial-targeted treatment.

bioRxiv · Jul 18, 2025 · PreprintCell Biology